Resultados de Búsqueda
Altering Overuse of Cardiac Telemetry in Non–Intensive Care Unit Settings by Hardwiring the Use of American Heart Association Guidelines.
Less Is More Collection - JAMA Network
Dressler R,et al. JAMA Intern Med. 2014;174(11):1852-1854
For further information please visit the website of the initiative (link below)
ver más ... 2014A Call for Evidence-Based Telemetry Monitoring. The Beep Goes On.
Less Is More Collection - JAMA Network
Najafi N. JAMA Intern Med. 2014;174(11):1855-1856.
Technology evolves quickly; scientific evidence builds slowly. This is as true for inpatient cardiac telemetry monitoring as it is for other medical interventions. Telemetry was invented in 1949 and saw widespread use in the 1960s for detecting arrhythmias in patients with myocardial infarction. Today the use of telemetry is ubiquitous on medical and surgical wards, often for patients without active cardiac conditions.
ver más ... 2014Balanced Coagulopathy in Cirrhosis—Clinical Implications. A Teachable Moment.
Less Is More Collection - JAMA Network
Roberts J, et al. JAMA Intern Med. 2014;174(11):1723-1724.
For further information please visit the website of the initiative (link below)
ver más ... 2014Use of Medications of Questionable Benefit in Advanced Dementia.
Less Is More Collection - JAMA Network
Tjia J et al. JAMA Intern Med. 2014;174(11):1763-1771.
Most nursing home residents with advanced dementia receive medications with questionable benefit that incur substantial associated costs.
ver más ... 2014Initial Choice of Oral Glucose-Lowering Medication for Diabetes Mellitus. A Patient-Centered Comparative Effectiveness Study.
Less Is More Collection - JAMA Network
Berkowitz S, et al.JAMA Intern Med. 2014;174(12):1955-1962
Despite guidelines, only 57.8% of individuals began diabetes treatment with metformin. Beginning treatment with metformin was associated with reduced subsequent treatment intensification, without differences in rates of hypoglycemia or other adverse clinical events. These findings have significant implications for quality of life and medication costs.
For further information please visit the website of the initiative (link below)